Skip to content

Achieve Life Sciences ACHV Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-496.1%-257.7%
Return on assets-172%-77.2pp-135.9%+1.4pp-104.7%-13.6pp-81.5%-22.7pp-94.8%-34.6pp
Liquidity
Current ratio2.6×-0.9×4.4×-1.1×5.1×-1.6×6.6×+2.1×3.5×+0.2×
Quick ratio2.6×-0.9×4.4×-1.1×5.1×-1.6×6.6×+2.1×3.5×+0.2×
Cash ratio2.4×+0.5×2.3×+0.4×3.3×+1.9×6.1×+5.0×1.8×-1.4×
Leverage
Debt-to-equity0.5×+0.4×0.2×+0.2×0.1×
Debt-to-assets0.2×+0.1×0.1×+0.1×0.0×-0.1×-0.2×
Per Share
Book value per share$0.20-32.5%$0.49-24.2%$0.66-27.9%$1.20-2.5%$0.30-85.0%
Valuation
Market capitalization$585.16M+404%$264.57M+119%$160.98M-1.1%$132.15M-18.1%$92.61M-40.5%
Enterprise value$562.71M+439%$247.41M+128%$130.33M-15.0%$81.58M-47.5%$80.9M-24.0%
Price / book54.8×+43.5×12.3×+6.5×4.8×3.2×
Earnings yield-8.9%+30.8pp-20.7%+12.2pp-32.5%-12.3pp-38.2%-21.1pp-49.8%-32.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Achieve Life Sciences's ratios come from?
Every ratio is computed from Achieve Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.